14-3-3酸化抑制了14-3-3θ调节LRRK2激酶活性和毒性的能力
Rudradip Pattanayak1, Roschongporn Ekkatine1, Chad M Petit2
1Center for Neurodegeneration and Experimental Therapeutics, Department of Neurology, Heersink School of Medicine, University of Alabama at Birmingham, 1719 Sixth Avenue South, Civitan International Research Building 510, Birmingham, AL 35294, United States.
Human molecular genetics
|September 26, 2024
概括
14-3-3θ的酸化破坏了它与LRRK2的相互作用,增加了LRRK2激酶活性,并促进了帕金森病 (PD) 的发病. 这一发现为PD机制和潜在的治疗点提供了新的见解.
科学领域:
- 神经科学是一个神经科学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 氨酸丰富的重复激酶2 (LRRK2) 的突变是帕金森病 (PD) 的常见遗传原因.
- LRRK2激酶活性是PD病变发生的一个关键因素.
- 14-3-3蛋白质,包括14-3-3θ异型,是LRRK2激酶活性的关键调节者.
研究的目的:
- 研究14-3-3θ在232血清 (S232) 的酸化对其调节LRRK2激酶活性的能力的影响.
- 确定14-3-3θ/LRRK2相互作用在PD中的作用.
- 评估针对PD中的14-3-3θ酸化的治疗潜力.
主要方法:
- 使用的野生型,S232A (非酸化),和S232D (相仿) 14-3-3θ 突变.
- 测量了LRRK2激酶活性 (S1292和T1503的自酸化,Rab10的酸化) 和LRRK2-14-3-3θ的相互作用 (共免疫沉,近位结合试验).
- 在用G2019S LRRK2和14-3-3θ突变治疗的初级培养物中评估神经元缩短.
主要成果:
- 相仿S232D 14-3-3θ突变对LRRK2激酶活性的影响很小,与野生型和S232A突变不同.
- 与化T2524 LRRK2的相互作用对14-3-3θ的调节功能至关重要;S232A 14-3-3θ未能抑制G2019S/T2524A LRRK2.
- S232D突变没有保护G2019SLRRK2诱导的神经元缩短,而S232A突变是保护性的.
结论:
- 在S232处14-3-3θ的酸化使其在T2524处与LRRK2的相互作用不稳定.
- 这种不稳定的相互作用导致LRRK2激酶活性增加,并促进PD相关的神经毒性.
- 向14-3-3θ酸化代表了帕金森病的潜在治疗策略.
相关概念视频
Protein Kinases and Phosphatases
13.1K
Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
13.1K
Phosphorylation
50.1K
The addition or removal of phosphate groups from proteins is the most common chemical modification that regulates cellular processes. These modifications can affect the structure, activity, stability, and localization of proteins within cells as well as their interactions with other proteins.
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
During phosphorylation, protein kinases transfer the terminal phosphate group of ATP to specific amino acid side chains of substrate proteins. Serine, threonine, and tyrosine are the most commonly...
50.1K
PI3K/mTOR/AKT Signaling Pathway
3.4K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.4K
Lysosomal Hydrolases
3.8K
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
3.8K
Receptor Tyrosine Kinases
12.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.5K
Amplifying Signals via Enzymatic Cascade
8.4K
When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze...
8.4K


